Financing · Biotech
Paite Meisheng adds Triwise Capital in February financing
The Nanjing company develops innovative medicines and formulations for pets.
Paite Meisheng completed financing with participation from Triwise Capital, according to a February report citing registry information published on February 5. The amount was not disclosed.
The company develops veterinary medicines and formulations for pets, combining drug discovery with clinical expertise. Its research addresses pet disease prevention and treatment.
The February investment preceded the company’s separate July Series A led by CITIC Group Agricultural Industry Fund.
Funding history
Financing · This roundUndisclosed